Alvotech Says FDA Closes Inspection Of Manufacturing Facility In Reykjavik, Iceland; FDA Confirms Inspection Classification Of Manufacturing Site Is Voluntary Action Indicated
Alvotech (NASDAQ:ALVO, ALVO-SDB))) (the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S.
The FDA finished checking Alvotech's factory in Iceland and found things needed improvement, but it wasn't a serious failure. When regulators finish inspections and ask for fixes, it usually means the company can keep working while it makes changes.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.